-
Labcorp Stock Gains From Biopharma Business Amid FX Woe
Monday, October 7, 2024 - 3:08pm | 908Labcorp Holdings, Inc. (NYSE: LH) or Labcorp benefits from the solid execution of its strategic priorities. Investment in targeted high-growth areas should drive the momentum. The company faces headwinds from macroeconomic uncertainties and growing foreign exchange issues. The stock carries a Zacks...
-
Why Fortrea Holdings Shares Are Gaining Today
Tuesday, October 17, 2023 - 8:23am | 439Activist hedge fund Starboard Value holds a stake of around 8.7% in contract-research organization Fortrea Holdings Inc. (NASDAQ: FTRE), according to an exchange filing. The activist investor plans to push for changes that could boost margins among other initiatives...
-
Is There A Blood Test for Alzheimer's? Progress Underway, But Not Quite Ready
Wednesday, October 11, 2023 - 1:27pm | 463Blood tests for diagnosing Alzheimer's disease are eagerly awaited, but it may be a couple of years before they become a routine diagnostic tool. While several blood tests for Alzheimer's diagnosis are in development, none are approved by regulators or insurance reimbursement. Some...
-
FDA Readies Proposal for Increased Oversight on Lab-developed Tests
Thursday, June 8, 2023 - 1:00pm | 322The FDA is preparing to increase regulation of a widely used class of tests conducted by laboratories to detect cancer, measure cholesterol, and identify other health issues. The FDA is developing a proposal to ensure these tests' effectiveness and accuracy. While the timing of the...
-
Exact Sciences Serves Investors Exactly What They Wished For
Tuesday, May 16, 2023 - 3:38pm | 778Diagnostic and cancer test products provider Exact Sciences Corp. (NASDAQ: EXAS) saw its shares spike over 17% on its Q1 2023 earnings results. The company is known for its flagship colon cancer detection test Cologuard. This is a patient-friendly, non-invasive stool-based DNA test that users can...
-
Labcorp Forecasts Steeper Fall In COVID-19 Testing Sales
Thursday, October 27, 2022 - 12:16pm | 238Laboratory Corp of America Holdings (NYSE: LH) posted Q3 revenues of $3.61 billion, a decrease of 11.2% Y/Y, missing the consensus of $3.79 billion. The 10.7% decrease in organic revenue was driven by an 11.8% decrease in COVID-19 Testing, partially offset by a 1.1% increase in the...
-
Insiders Selling AutoNation, Hershey And This Healthcare Stock
Thursday, September 29, 2022 - 7:53am | 558Gold futures traded lower this morning on Thursday. Investors, meanwhile, focused on some notable insider trades. When insiders sell shares, it indicates their concern in the company’s prospects or that they view the stock as being overpriced. Either way, this signals an opportunity to go...
-
Airbnb To $145? Here Are 5 Other Price Target Changes For Monday
Monday, August 1, 2022 - 6:48am | 313Keybanc cut the price target on Airbnb, Inc. (NASDAQ: ABNB) from $195 to $145. However, Keybanc analyst Justin Patterson maintained the stock with an Overweight. Airbnb shares rose 0.7% to $111.70 in pre-market trading. Wells Fargo boosted Colgate-Palmolive Company (NYSE: CL) price target from...
-
Benzinga Before The Bell: Apple's Latest Move For Self-Driving Car Project, Monkeypox Is A National Emergency, Spirit-Jet Blue Merger And Other Top Financial Stories Thursday, July 28
Thursday, July 28, 2022 - 7:32am | 3109Reuters Monkeypox A Nationally Notifiable Condition, CDC Poised To Announce: Report Reuters reported that the U.S. Centers for Disease Control and Prevention (CDC) plans to make monkeypox infection a nationally notifiable condition. The CDC said that the designation would be effective from next...
-
Labcorp To Spin Off Its Clinical Trial Business, Posts Mixed Q2 Earnings
Thursday, July 28, 2022 - 6:44am | 348Laboratory Corp of America Holdings (NYSE: LH) plans to spin off its unit focused on the clinical development business. Wall Street Journal was the first to report the news. The clinical drug trial business operates as a Contract Research Organization, providing Phase I-IV...
-
LabCorp (LH) To Report Q2 Earnings: What's In The Cards?
Wednesday, July 20, 2022 - 10:35am | 1188Laboratory Corporation of America Holdings (NYSE: LH), also known as LabCorp, is slated to report second-quarter 2022 results on Jul 28, before market open. In the last reported quarter, the company's adjusted earnings of $6.11 exceeded the Zacks Consensus Estimate by 3.9%. The company beat...
-
US Expands Monkeypox Testing Capacity To Five Commercial Lab Companies
Thursday, June 23, 2022 - 6:20am | 343The Department of Health and Human Services (HHS), through the Centers for Disease Control and Prevention (CDC), started shipping monkeypox tests to five commercial laboratory companies to increase monkeypox testing capacity and access. The companies include Aegis Science, Laboratory...
-
FDA Gives Nod To First Nonprescription COVID-19 Test That Also Detects Flu, RSV
Tuesday, May 17, 2022 - 6:29am | 274The FDA has authorized the first nonprescription test to detect Covid-19, influenza, and respiratory syncytial virus (RSV). The test, called the Labcorp Seasonal Respiratory Virus RT-PCR DTC Test, was developed by Laboratory Corp of America Holdings (NYSE: LH). It can be sold...
-
UnitedHealth Scoops Up Home-Health Firm LHC Group In $5.4B Deal
Tuesday, March 29, 2022 - 10:35am | 350UnitedHealth Group Inc (NYSE: UNH) has agreed to buy LHC Group Inc (NASDAQ: LHCG) for about $5.4 billion in cash. The acquisition by UnitedHealth's Optum health-services arm will add one of the country's largest home-health firms to a portfolio that already includes...
-
Labcorp's Q4 Earnings Beat Consensus Despite 15% Decline In COVID-19 Testing Sales
Thursday, February 10, 2022 - 8:40am | 313Laboratory Corp of America Holdings (NYSE: LH) Q4 FY21 revenue decreased 9.7% Y/Y to $4.06 billion, beating the consensus of $3.90 billion. The decrease was due to organic revenue decline of 10.3%, partially offset by acquisitions of 0.6% and foreign currency translation of 0.1%. The 10....